1. Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sjögren's syndrome. (3rd July 2019) Authors: van der Heijden, Eefje HM; Hartgring, Sarita AY; Kruize, Aike A; Radstake, Timothy RDJ; van Roon, Joel AG Journal: Expert review of clinical immunology Issue: Volume 15:Number 7(2019) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗